Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
30.56
+1.39 (4.77%)
At close: Apr 28, 2026, 4:00 PM EDT
30.80
+0.24 (0.79%)
After-hours: Apr 28, 2026, 7:50 PM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $3.06 billion as of April 28, 2026. Its market cap has increased by 115.20% in one year.
Market Cap
3.06B
Enterprise Value
1.97B
1-Year Change
115.20%
Ranking
Category
Stock Price
$30.56
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $3.06B, an increase of 833.66%. That is a compound annual growth rate of 43.17%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kailera Therapeutics | 2.78B |
| Kodiak Sciences | 2.77B |
| Soleno Therapeutics | 2.73B |
| Vera Therapeutics | 2.70B |
| IDEAYA Biosciences | 2.70B |
| Immunome | 2.67B |
| Enliven Therapeutics | 2.65B |
| Disc Medicine | 2.63B |